Safety and feasibility of chimeric antigen receptor T cell therapy after allogeneic hematopoietic cell transplantation in relapsed/ refractory B cell non-Hodgkin lymphoma. uri icon

Overview

publication date

  • May 21, 2019

Research

keywords

  • B-Lymphocytes
  • Immunotherapy, Adoptive
  • Lymphoma, Non-Hodgkin
  • Neoplasm Recurrence, Local
  • Receptors, Chimeric Antigen

Identity

PubMed Central ID

  • PMC8224498

Scopus Document Identifier

  • 85066140851

Digital Object Identifier (DOI)

  • 10.1038/s41375-019-0476-y

PubMed ID

  • 31114023

Additional Document Info

volume

  • 33

issue

  • 10